Q3 2022 Holdings
Filed 2022-11-14 | 31 holdings | $648.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-05-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tricida Inc(1T7)A | COM | 89610F101 | $94.8M | 9,050,064 | 14.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $71.8M | 4,563,962 | 11.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $60.2M | 4,038,117 | 9.3% |
| Relmada Therapeutics Inc(RLMD)A | COM | 75955J402 | $56.2M | 1,518,056 | 8.7% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $43.7M | 2,130,308 | 6.7% |
| GH Research PLC(GHRS)A | ORD SH | G3855L106 | $38.7M | 3,333,154 | 6.0% |
| Pliant Therapeutics Inc(PLRX)A | COM | 729139105 | $22.6M | 1,080,000 | 3.5% |
| Milestone Pharmaceuticals Inc(MIST)A | COM | 59935V107 | $22.3M | 2,425,737 | 3.4% |
| Terns Pharmaceuticals Inc(TERN)A | COM | 880881107 | $21.8M | 3,707,891 | 3.4% |
| Marinus Pharmaceuticals Inc(MRNS*)A | COM | 56854Q200 | $21.0M | 3,156,803 | 3.2% |
| Gossamer Bio Inc(GOSS)A | COM | 38341P102 | $20.9M | 1,747,000 | 3.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $19.9M | 3,220,050 | 3.1% |
| Instil Bio IncA | COM | 45783C101 | $19.9M | 4,105,779 | 3.1% |
| Akouos IncA | COM | 00973J101 | $18.9M | 2,800,566 | 2.9% |
| Dice Therapeutics IncA | COM | 23345J104 | $15.5M | 764,979 | 2.4% |
| Aerovate Therapeutics IncA | COM | 008064107 | $13.8M | 833,927 | 2.1% |
| LianBioA | SPONS ADR | 53000N108 | $10.8M | 5,378,341 | 1.7% |
| Fulcrum Therapeutics Inc(FULC)A | COM | 359616109 | $9.7M | 1,200,000 | 1.5% |
| Inozyme Pharma IncA | COM | 45790W108 | $7.3M | 2,709,987 | 1.1% |
| Ventyx Biosciences Inc(VTYX)A | COM | 92332V107 | $7.3M | 207,925 | 1.1% |
| Prometheus Biosciences IncA | COM | 74349U108 | $7.2M | 121,663 | 1.1% |
| Savara Inc(SVRA)A | COM | 805111101 | $7.1M | 4,555,038 | 1.1% |
| Provention Bio Inc(PRVBUSD)A | COM | 74374N102 | $5.0M | 1,118,653 | 0.8% |
| Altimmune Inc(ALT) | COM | 02155H200 | $4.7M | 369,306 | 0.7% |
| Trevi Therapeutics Inc(TRVI)A | COM | 89532M101 | $4.7M | 3,050,022 | 0.7% |
| Lyra Therapeutics Inc(LYRA)A | COM | 55234L105 | $4.6M | 924,170 | 0.7% |
| Immunocore Holdings PLC(IMCR)A | ADS | 45258D105 | $4.4M | 94,605 | 0.7% |
| aTyr Pharma Inc(ATYR)A | COM | 002120202 | $4.2M | 1,398,889 | 0.6% |
| Rallybio CorpA | COM | 75120L100 | $3.9M | 268,532 | 0.6% |
| Affimed NVA | COM | N01045108 | $2.9M | 1,428,571 | 0.5% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $2.1M | 75,000 | 0.3% |